Detalhe da pesquisa
1.
Switching from one infliximab biosimilar (CT-P13) to another infliximab biosimilar (SB2) in patients with chronic plaque psoriasis.
Br J Dermatol
; 183(2): 397-398, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32133618
2.
Persistent B Lymphocyte Depletion After an Ultralow Dose of Rituximab for Pemphigus Vulgaris.
J Investig Allergol Clin Immunol
; 28(5): 347-348, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30350792